Molecular Oncology Almanac
  • API
  • Approvals
  • Organizations
  • About
  • Contact

AKT1

About

Location: 14q32.33

Mappings

HGNC: HGNC:391

Ensembl: NM_001382430.1

NCBI: ENSG00000142208

Refseq: 207

View API

Biomarkers

AKT1 is involved in the following curated biomarkers.

Name Biomarker type Propositions Statements
AKT1 amplification Copy Number 3 4
AKT1 somatic variants Somatic Variant 3 4

Therapeutic response

Precision oncology relationships for therapeutic response involving this gene.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) AKT1 somatic variants, ER positive, HER2-negative Invasive Breast Carcinoma Capivasertib, Fulvestrant
Sensitivity (+) AKT1 somatic variants, HER2-negative, PR positive Invasive Breast Carcinoma Capivasertib, Fulvestrant
Sensitivity (+) AKT1 somatic variants, ER positive, HER2-negative, PR positive Invasive Breast Carcinoma Capivasertib, Fulvestrant
Sensitivity (+) AKT1 amplification, ER positive, HER2-negative Invasive Breast Carcinoma Capivasertib, Fulvestrant
Sensitivity (+) AKT1 amplification, HER2-negative, PR positive Invasive Breast Carcinoma Capivasertib, Fulvestrant
Sensitivity (+) AKT1 amplification, ER positive, HER2-negative, PR positive Invasive Breast Carcinoma Capivasertib, Fulvestrant
Sensitivity (+) AKT1 amplification, ER positive, HER2-negative Invasive Breast Carcinoma Capivasertib, Fulvestrant
Sensitivity (+) AKT1 somatic variants, ER positive, HER2-negative Invasive Breast Carcinoma Capivasertib, Fulvestrant

Please review our privacy policy and terms before use.
API | Bluesky | Contact | GitHub

  • Dana-Farber logo
  • University of Limerick Digital Health Center logo
  • eHealthHub logo